Gillian M. Fenton, Esq., CLP is currently executive director of LST Strategies LLC, a specialty law practice dedicated to life science transactions (https://lifesciencetransactions.com).  She is also a Practitioner in Residence at the Intellectual Property Policy Institute (About IPPI – UA LAW IP), and a business consultant to Held IP.  Previously, she served GSK (GlaxoSmithKline) as Vaccines Special Counsel for Innovation and Government Collaborations.  Gillian supported a wide variety of international business development transactions, R&D collaborations and strategic alliances to feed the pipeline for GSK’s vaccines and infectious diseases business segment.  She also negotiated and managed GSK Vaccines’ R&D U.S. Government Contracts, patent licenses, and scientific collaborations with NIH/NIAID, BARDA, DARPA, CARB-X and NIIMBL.  Before joining GSK, Gillian was VP, Chief Intellectual Property Counsel at Emergent BioSolutions Inc., where she founded the IP department and supported all IP aspects of the company’s IPO and subsequent 9 years of growth through M&A in the vaccines, biodefense, and global health fields.

Gillian is an active member of the Licensing Executives Society (LES, USA & Canada), having served as the society President in 2020-2021.  Gillian’s contributions to LES and to the field of licensing were recognized with the society’s Frank Barnes Award in October 2022 and the President’s Award in October 2025.  She remains active in LES as Co-Chair of the Education Committee.  Gillian has been listed in the IAM 300 since October 2023.

Education: J.D. cum laude, Suffolk University Law School; B.Sc. Biochemistry, Trinity College.

Admissions: MA, MD, DC.  Registered U.S. Patent Attorney.